Get the app
public
ios_share
OncoPharm
chevron_right
Afamitresgene Autoleucel & Vorasidenib
Aug 8, 2024
12:29
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
A new cellular therapy is approved for synovial sarcoma and the anticipated approval has occurred for the dual IDH1/IDH2 inhibitor, vorasidenib.
